Canada markets closed

Timber Pharmaceuticals, Inc. (TMBR)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.0800-0.0900 (-7.69%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 539.79M
Enterprise Value 340.4M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)85.09
Price/Book (mrq)N/A
Enterprise Value/Revenue 386.40
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-52.21%
S&P500 52-Week Change 333.63%
52 Week High 33.6500
52 Week Low 30.6650
50-Day Moving Average 31.2282
200-Day Moving Average 31.4850

Share Statistics

Avg Vol (3 month) 31.91M
Avg Vol (10 day) 31.72M
Shares Outstanding 536.84M
Implied Shares Outstanding 6N/A
Float 32.06M
% Held by Insiders 112.99%
% Held by Institutions 13.98%
Shares Short (May 27, 2021) 44.22M
Short Ratio (May 27, 2021) 43.1
Short % of Float (May 27, 2021) 413.47%
Short % of Shares Outstanding (May 27, 2021) 411.45%
Shares Short (prior month Apr. 29, 2021) 44.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 18, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3May 18, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-4,092.23%

Management Effectiveness

Return on Assets (ttm)-191.35%
Return on Equity (ttm)-907.94%

Income Statement

Revenue (ttm)467.64k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)51.40%
Gross Profit (ttm)-14.65M
Net Income Avi to Common (ttm)-13.62M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.5M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)903.92k
Total Debt/Equity (mrq)11.74
Current Ratio (mrq)6.59
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-8.53M
Levered Free Cash Flow (ttm)-14.93M